CG Oncology, Inc. CGON
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-01-25
CG Oncology, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 1,976,070 | $62.4M |
| Point72 Asset Management, L.P. | 425,292 | $28.8M |
| CITADEL ADVISORS LLC | 267,815 | $18.1M |
| AQR CAPITAL MANAGEMENT LLC | 114,342 | $7.7M |
| D. E. Shaw & Co., Inc. | 46,610 | $3.2M |
| MILLENNIUM MANAGEMENT LLC | 20,000 | $1.4M |
Source: SEC EDGAR filings · CIK 0001991792 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.